Shiftwork and Prostate-Specific Antigen in the National Health and Nutrition Examination Survey

被引:60
|
作者
Flynn-Evans, Erin E. [1 ,2 ]
Mucci, Lorelei [3 ]
Stevens, Richard G. [4 ]
Lockley, Steven W. [1 ,2 ]
机构
[1] Brigham & Womens Hosp, Div Sleep Med, Dept Med, Boston, MA 02115 USA
[2] Harvard Univ, Sch Med, Dept Med, Div Sleep Med, Boston, MA 02114 USA
[3] Harvard Univ, Sch Publ Hlth, Dept Epidemiol, Boston, MA 02115 USA
[4] Univ Connecticut, Ctr Hlth, Dept Community Med, Farmington, CT USA
来源
JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE | 2013年 / 105卷 / 17期
关键词
CANCER INCIDENCE; SLEEP DURATION; BREAST-CANCER; RISK; MELATONIN; COHORT; WORK; OCCUPATION; MORTALITY; INDUSTRY;
D O I
10.1093/jnci/djt169
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Background Shiftwork has been implicated as a risk factor for prostate cancer. Results from prior studies have been mixed but generally support an association between circadian disruption and prostate cancer. Our aim was to investigate the relationship between shiftwork and prostate-specific antigen (PSA) test obtained as part of the National Health and Nutrition Examination Survey (NHANES) study. Methods We combined three NHANES surveys (2005-2010) to obtain current work schedule among employed men aged 40 to 65 years with no prior history of cancer (except nonmelanoma skin cancer). Men who reported working regular night shifts or rotating shifts were considered shiftworkers. We obtained the total and percentage free PSA test results for these men and dichotomized total PSA into less than 4.0 ng/mL or 4.0 ng/mL or greater and total PSA of 4.0 ng/mL or greater combined with percentage free PSA less than or equal to 25%. Using multivariable logistic regression models, we compared PSA level among current shiftworkers and nonshiftworkers. All statistical tests were two-sided. Results We found a statistically significant, age-adjusted association between current shiftwork and elevated PSA at the 4.0 ng/mL or greater level (odds ratio = 2.48, 95% confidence interval [CI] = 1.08 to 5.70; P = .03). The confounder-adjusted odds ratio was 2.62 (95% CI = 1.16 to 5.95; P = .02). The confounder-adjusted odds ratio for those with total PSA of 4.0 ng/mL or greater and free PSA less than or equal to 25% was 3.13 (95% CI = 1.38 to 7.09; P = .01). Conclusions We observed a strong positive association with shiftwork and elevated PSA level. Our data support the notion that sleep or circadian disruption is associated with elevated PSA, indicating that shiftworking men likely have an increased risk of developing prostate cancer.
引用
收藏
页码:1292 / 1297
页数:6
相关论文
共 50 条
  • [31] Prostate-specific antigen for treatment monitoring
    Graefen, M.
    Froehner, M.
    Wirth, M.
    UROLOGE, 2011, 50 (03): : 309 - +
  • [32] Prostate-specific antigen: Aesop tale?
    Mongiat-Artus, P.
    Desgrandchamps, F.
    REVUE DE MEDECINE INTERNE, 2010, 31 (07): : 467 - 468
  • [33] Empirical estimates of prostate cancer overdiagnosis by age and prostate-specific antigen
    Vickers, Andrew J.
    Sjoberg, Daniel D.
    Ulmert, David
    Vertosick, Emily
    Roobol, Monique J.
    Thompson, Ian
    Heijnsdijk, Eveline A. M.
    De Koning, Harry
    Atoria-Swartz, Coral
    Scardino, Peter T.
    Lilja, Hans
    BMC MEDICINE, 2014, 12
  • [34] Managing Localized Prostate Cancer in the Era of Prostate-Specific Antigen Screening
    Brooks, James D.
    CANCER, 2013, 119 (22) : 3906 - 3909
  • [35] Prostate-Specific Antigen (PSA) Screening for Prostate Cancer Revisiting the Evidence
    Carter, H. Ballentine
    JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2018, 319 (18): : 1866 - 1868
  • [36] Baseline Prostate-Specific Antigen Testing at a Young Age
    Loeb, Stacy
    Carter, H. Ballentine
    Catalona, William J.
    Moul, Judd W.
    Schroder, Fritz H.
    EUROPEAN UROLOGY, 2012, 61 (01) : 1 - 7
  • [37] Prostate-specific Antigen (PSA) Density and Free to Total PSA Ratio in Diagnosing Prostate Cancer with Prostate-Specific Antigen Levels of 4.0 ng/ml or Less
    Liu, Xin
    Tang, Jie
    Fei, Xiang
    Li, Qiu-Yang
    IRANIAN JOURNAL OF PUBLIC HEALTH, 2015, 44 (11) : 1466 - 1472
  • [38] Divergent Responses to Mammography and Prostate-Specific Antigen Recommendations
    Martinez, Kathryn A.
    Rothberg, Michael B.
    AMERICAN JOURNAL OF PREVENTIVE MEDICINE, 2017, 53 (04) : 533 - 536
  • [39] PROSTATE-SPECIFIC ANTIGEN VELOCITY BEFORE AND AFTER ELIMINATION OF FACTORS THAT CAN CONFOUND THE PROSTATE-SPECIFIC ANTIGEN LEVEL
    Park, Jessica J.
    Chen, Ming-Hui
    Loffredo, Marian
    D'Amico, Anthony V.
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2012, 82 (03): : 1217 - 1221
  • [40] Prostate-specific antigen in nipple aspiration fluid: Menstrual cycle variability and correlation with serum prostate-specific antigen
    Mitchell, G
    Sibley, PEC
    Wilson, APM
    Sauter, E
    A'Hern, R
    Eeles, RA
    TUMOR BIOLOGY, 2002, 23 (05) : 287 - 297